サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1494558

北米の自動体外式除細動器市場の2030年予測-地域別分析-タイプ別、エンドユーザー別

North America Automated External Defibrillators Market Forecast to 2030 - Regional Analysis - by Type (Fully-Automated External Defibrillators and Semi- Automated External Defibrillators) and End User (Hospitals & Clinics, Homecare, and Others)
出版日: | 発行: The Insight Partners | ページ情報: 英文 66 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.53円
北米の自動体外式除細動器市場の2030年予測-地域別分析-タイプ別、エンドユーザー別
出版日: 2024年04月05日
発行: The Insight Partners
ページ情報: 英文 66 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の自動体外式除細動器市場は、2022年の6億8,103万米ドルから2030年には9億8,355万米ドルに成長すると予測されています。2022～2030年のCAGRは4.7%を記録すると推定されます。

心血管疾患の有病率の増加が北米の自動体外式除細動器市場を牽引

心血管疾患（CVD）は、世界的に罹患率と死亡率の主要な原因となっています。米国疾病予防管理センター（CDC）によると、2021年には心血管疾患による死亡の6人に1人が脳卒中によるものでした。世界保健機関（WHO）の報告によると、世界では毎年1,790万人がCVDが原因で死亡しており、これは全死亡例の32％に相当します。さらに、CVDに関連した死亡の5人に4人は心臓発作と脳卒中によるものです。食生活の乱れ、肥満、運動不足、タバコ、過度の飲酒など、不健康な生活習慣がCVDの主要原因です。CVD患者の急増は、病院におけるCVD患者の蘇生とケアに不可欠なツールとして、除細動器に対する高い需要をもたらしています。さまざまな地域で国民医療費と可処分世帯所得が増加していることから、CVDを管理するために除細動器の使用が増加すると予想されます。さらに、病院における重要な機器として除細動器への需要が高まる中、自動体外式除細動器は、突然の心停止（SCA）患者の蘇生に適していることから、注目すべき牽引力となっています。このように、CVDの発生率の増加は、病院、家庭、その他の医療環境における自動体外式除細動器を含む除細動器の需要を促進しています。

北米の自動体外式除細動器市場概要

北米の自動体外式除細動器市場は米国、カナダ、メキシコに区分されます。北米の自動体外式除細動器市場は米国、カナダ、メキシコに区分されます。米国は自動体外式除細動器の最大市場です。呼吸器疾患の増加、糖尿病人口の増加、呼吸器疾患に対する意識の高まりが市場を牽引しています。米国は、心血管疾患（CVD）の発生率の増加、自動体外式除細動器の存在に対する意識の高まり、この地域における大手製薬会社の存在、十分に整備された医療インフラの存在など、複数の要因により、自動体外式除細動器の最大市場になると予測されています。さらに、技術の進歩によりさまざまな新しい除細動器が開発されています。

冠動脈疾患（CAD）は、先進国における罹患率と死亡率の主要原因の一つです。米国疾病管理センターの調査によると、CADによる死亡者数は年間610万人（推定死亡者数の4人に1人）であり、米国における主要な死因となっています。さらに、65歳以上の人口は2012～2050年の間に増加すると予測されており、高齢者に対する心血管疾患の影響について理解を深める必要性が高まっています。

さらに、人々の間で心疾患の有病率が上昇していることも、自動体外式除細動器市場の成長に寄与しています。米国心臓協会（AHA）の「心臓病と脳卒中の統計2019」によると、米国では約1億2,150万人の成人がCVDに罹患しており、毎年805万人の米国人が心臓発作に苦しんでいます。また、CDCによれば、米国では毎年795万人が脳卒中に苦しんでいます。2019年に発表されたクレアモント大学院大学のDIL-a Conversational Agent for Heart Failure Patientsによると、心血管疾患と脳卒中の治療に関連する間接的・直接的コストは、医療費と生産性損失の両方を含めて3,297億米ドル以上になると予想されています。そのため、患者の治療費は増加します。

高血圧は心臓病、脳卒中、心停止の主要危険因子の一つであるが、治療可能性が高いです。米国心臓協会の2023年の報告によると、20歳以上の米国人の約50％、すなわち1億2,200万人以上が高血圧です。高血圧の有病率は今後数年で上昇することが予想されるため、心血管疾患の発生率も将来的に上昇することが予想されます。

北米の自動体外式除細動器市場の収益と2030年までの予測（金額）

北米の自動体外式除細動器市場セグメンテーション

北米の自動体外式除細動器市場は、タイプ、エンドユーザー、国に区分されます。

タイプ別では、北米の自動体外式除細動器市場は全自動体外式除細動器と半自動体外式除細動器に二分されます。2022年の北米自動体外式除細動器市場では、全自動体外式除細動器セグメントが大きなシェアを占めています。

エンドユーザー別では、北米の自動体外式除細動器市場は病院＆クリニック、在宅医療、その他に区分されます。2022年の北米自動体外式除細動器市場では、病院＆クリニックセグメントが最大のシェアを占めています。

国別に見ると、北米の自動体外式除細動器市場は米国、カナダ、メキシコに区分されます。2022年の北米自動体外式除細動器市場は米国が支配的です。

旭化成株式会社、Koninklijke Philips NV、Mediana Co Ltd、日本光電株式会社、Schiller AG、Shenzhen Mindray Bio-Medical Electronics Co Ltd、Stryker Corpは、北米の自動体外式除細動器市場で事業を展開している大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブ概要

第3章 調査手法

  • 対象範囲
  • 2次調査
  • 1次調査

第4章 北米自動体外式除細動器市場：主要産業力学

  • 主要市場促進要因
    • 心血管疾患の有病率の増加
    • 自動体外式除細動器に関する教育・啓発プログラムの増加
  • 市場抑制要因
    • 自動体外式除細動器に関する性能問題
  • 市場機会
    • 新興市場でのプレゼンスを拡大するための主要市場参入企業の戦略
  • 今後の動向
    • 技術の進歩
  • 影響分析

第5章 自動体外式除細動器市場：北米市場分析

  • 北米の自動体外式除細動器市場収益（2020～2030年）

第6章 北米の自動体外式除細動器市場-タイプ別収益と2030年までの予測

  • イントロダクション
  • 北米の自動体外式除細動器市場：2022年と2030年のタイプ別売上高シェア（%）
  • 全自動体外式除細動器
  • 半自動体外式除細動器

第7章 北米の自動体外式除細動器市場-エンドユーザー別収益と2030年までの予測

  • イントロダクション
  • 北米の自動体外式除細動器市場：2022年と2030年のエンドユーザー別売上高シェア（%）
  • 病院＆クリニック
  • 在宅医療
  • その他

第8章 北米の自動体外式除細動器市場：国別分析

  • 北米
    • 米国
    • カナダ
    • メキシコ

第9章 自動体外式除細動器市場-業界情勢

  • イントロダクション
  • 有機的成長戦略
  • 無機的成長戦略

第10章 企業プロファイル

  • Shenzhen Mindray Bio-Medical Electronics Co Ltd
  • Stryker Corp
  • Schiller AG
  • Mediana Co Ltd
  • Nihon Kohden Corp
  • Asahi Kasei Corp
  • Koninklijke Philips NV

第11章 付録

図表

List Of Tables

  • Table 1. North America Automated External Defibrillators Market Segmentation
  • Table 2. US: Automated External Defibrillator Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 3. US: Automated External Defibrillator Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 4. Canada: Automated External Defibrillator Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 5. Canada: Automated External Defibrillator Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 6. Mexico: Automated External Defibrillator Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 7. Mexico: Automated External Defibrillator Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 8. Recent Organic Growth Strategies in Automated External Defibrillators Market
  • Table 9. Recent Inorganic Growth Strategies in the Automated External Defibrillators Market
  • Table 10. Glossary of Terms, North America Automated External Defibrillators Market

List Of Figures

  • Figure 1. North America Automated External Defibrillators Market Segmentation, By Country
  • Figure 2. Key Insights
  • Figure 3. North America Automated External Defibrillators Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. North America Automated External Defibrillators Market Revenue (US$ Mn), 2020 - 2030
  • Figure 6. North America Automated External Defibrillators Market Revenue Share, by Type 2022 & 2030 (%)
  • Figure 7. Fully-Automated External Defibrillators: North America Automated External Defibrillators Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Semi-Automated External Defibrillators: North America Automated External Defibrillators Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. North America Automated External Defibrillators Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 10. Hospitals and Clinics: North America Automated External Defibrillators Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Home Care Settings: North America Automated External Defibrillators Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Others: North America Automated External Defibrillators Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. North America Automated External Defibrillator Market, By Key Country - Revenue (2022) (US$ Million)
  • Figure 14. North America: Automated External Defibrillator Market, By Countries, 2022 And 2030 (%)
  • Figure 15. US: Automated External Defibrillator Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 16. Canada: Automated External Defibrillator Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 17. Mexico: Automated External Defibrillator Market Revenue and Forecast to 2030 (US$ Mn)
目次
Product Code: BMIRE00030020

The North America automated external defibrillators market is expected to grow from US$ 681.03 million in 2022 to US$ 983.55 million by 2030. It is estimated to record a CAGR of 4.7% from 2022 to 2030.

Increasing Prevalence of Cardiovascular Diseases Drives North America Automated External Defibrillators Market

Cardiovascular diseases (CVDs) are the leading cause of morbidity and mortality globally. As per the Centers for Disease Control and Prevention (CDC), in 2021, 1 in 6 deaths from cardiovascular disease was due to stroke. The World Health Organization (WHO) reported that 17.9 million die globally due to CVD every year, i.e., 32% of all mortality cases. Furthermore, 4 out of 5 CVD-related mortalities are due to heart attacks and strokes. Unhealthy lifestyle habits, including poor diet, obesity, physical inactivity, tobacco consumption, and excess alcohol consumption, are the leading causes of CVDs. The surging cases of CVDs result in high demand for defibrillators as an essential tool for the resuscitation and care of CVD patients in hospitals. With a rise in national healthcare expenditures and disposable household incomes in various regions, the use of defibrillators is expected to increase in order to manage CVD. Furthermore, amid such high demands for defibrillators as a vital instrument in hospitals, automated external defibrillators are gaining notable traction owing to their enhanced suitability in the resuscitation of persons having sudden cardiac arrest (SCA). Thus, the growing incidence of CVDs drives the demand for defibrillators, including automated external defibrillators, in hospitals, homes, and other healthcare settings.

North America Automated External Defibrillators Market Overview

The Automated External Defibrillator market in North America is segmented into the US, Canada, and Mexico. The Automated External Defibrillator market in North America is segmented into the US, Canada, and Mexico. The US is the largest market for automated external defibrillator. The market is prominently driven by an extensive rise in respiratory diseases, a big pool of diabetic population, increase in awareness about respiratory diseases among the population. The US is projected to be the largest market for automated external defibrillators due to multiple factors such as an increase in the incidence of cardiovascular disease (CVDs), rising awareness about the presence of automatic defibrillators, the presence of leading pharmaceutical companies in this region, and the existence of fully developed healthcare infrastructure. Moreover, technological advancements have resulted in the development of various novel defibrillators.

Coronary artery disease (CAD) is among the leading causes of morbidity and mortality in developed countries. According to the Centers for Disease Control research, CAD accounts for ~6,10,000 deaths annually (estimated 1 in 4 deaths), which makes it the leading cause of death in the US. Furthermore, the population of people aged 65 and above is predicted to increase between 2012 and 2050, which boosts the need for a greater understanding of the impact of cardiovascular diseases on older adults.

In addition, the rising prevalence of cardiac conditions among people contributes to the automated external defibrillator market growth. Per the American Heart Association's (AHA) "heart disease and Stroke Statistics 2019", approximately 121.5 million adults in the US are suffering from CVDs, and every year 8,05,000 Americans suffer from a heart attack. In addition, as per the CDC, ~7,95,000 people in the US suffer from cerebrovascular stroke every year. As per DIL-a Conversational Agent for Heart Failure Patients by Claremont Graduate University published in 2019-the indirect and direct costs associated with the treatment of cardiovascular diseases and stroke are anticipated to be more than US$ 329.7 billion, which includes both health expenditures and productivity loss. Therefore, the cost of the treatments increases for the patients.

Hypertension is one of the major risk factors for heart diseases, strokes, and cardiac arrests, but it is highly treatable. According to a 2023 report from the American Heart Association, approximately 50% of Americans aged 20 years and above, i.e., more than 122 million people, have high blood pressure. The prevalence of hypertension is expected to rise in the coming years; therefore, it is anticipated that the incidences of cardiovascular diseases are also likely to increase in the future.

North America Automated External Defibrillators Market Revenue and Forecast to 2030 (US$ Million)

North America Automated External Defibrillators Market Segmentation

The North America automated external defibrillators market is segmented into type, end user, and country.

Based on type, the North America automated external defibrillators market is bifurcated into fully-automated external defibrillators and semi- automated external defibrillators. The fully-automated external defibrillators segment held a larger share of the North America automated external defibrillators market in 2022.

Based on end user, the North America automated external defibrillators market is segmented into hospitals & clinics, homecare, and others. The hospitals & clinics segment held the largest share of the North America automated external defibrillators market in 2022.

Based on country, the North America automated external defibrillators market is segmented into the US, Canada, and Mexico. The US dominated the North America automated external defibrillators market in 2022.

Asahi Kasei Corp, Koninklijke Philips NV, Mediana Co Ltd, Nihon Kohden Corp, Schiller AG, Shenzhen Mindray Bio-Medical Electronics Co Ltd, and Stryker Corp are some of the leading companies operating in the North America automated external defibrillators market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Automated External Defibrillators Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 Increasing Prevalence of Cardiovascular Diseases
    • 4.1.2 Rising Training and Awareness Programs on Automated External Defibrillators
  • 4.2 Market Restraints
    • 4.2.1 Performance Issues Related to Automated External Defibrillators
  • 4.3 Market Opportunities
    • 4.3.1 Strategies by Key Market Players to Expand Presence in Emerging Markets
  • 4.4 Future Trends
    • 4.4.1 Technological Advancements
  • 4.5 Impact Analysis:

5. Automated External Defibrillators Market - North America Market Analysis

  • 5.1 North America Automated External Defibrillators Market Revenue (US$ Mn), 2020 - 2030

6. North America Automated External Defibrillators Market - Revenue and Forecast to 2030 - by Type

  • 6.1 Overview
  • 6.2 North America Automated External Defibrillators Market Revenue Share, by Type 2022 & 2030 (%)
  • 6.3 Fully-Automated External Defibrillators
    • 6.3.1 Overview
    • 6.3.2 Fully-Automated External Defibrillators: North America Automated External Defibrillators Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Semi-Automated External Defibrillators
    • 6.4.1 Overview
    • 6.4.2 Semi-Automated External Defibrillators: North America Automated External Defibrillators Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Automated External Defibrillators Market - Revenue and Forecast to 2030 - by End User

  • 7.1 Overview
  • 7.2 North America Automated External Defibrillators Market Revenue Share, by End User 2022 & 2030 (%)
  • 7.3 Hospitals and Clinics
    • 7.3.1 Overview
    • 7.3.2 Hospitals and Clinics: North America Automated External Defibrillators Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Home Care Settings
    • 7.4.1 Overview
    • 7.4.2 Home Care Settings: North America Automated External Defibrillators Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: North America Automated External Defibrillators Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Automated External Defibrillators Market - Country Analysis

  • 8.1 North America
    • 8.1.1 North America: Automated External Defibrillator Market, by Country
      • 8.1.1.1 US
        • 8.1.1.1.1 Overview
        • 8.1.1.1.2 US: Automated External Defibrillator Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.1.3 US: Automated External Defibrillator Market, by Type
        • 8.1.1.1.4 US: Automated External Defibrillator Market, by End User
      • 8.1.1.2 Canada
        • 8.1.1.2.1 Overview
        • 8.1.1.2.2 Canada: Automated External Defibrillator Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.2.3 Canada: Automated External Defibrillator Market, by Type
        • 8.1.1.2.4 Canada: Automated External Defibrillator Market, by End User
      • 8.1.1.3 Mexico
        • 8.1.1.3.1 Overview
        • 8.1.1.3.2 Mexico: Automated External Defibrillator Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.3.3 Mexico: Automated External Defibrillator Market, by Type
        • 8.1.1.3.4 Mexico: Automated External Defibrillator Market, by End User

9. Automated External Defibrillators Market-Industry Landscape

  • 9.1 Overview
  • 9.2 Organic Growth Strategies
    • 9.2.1 Overview
  • 9.3 Inorganic Growth Strategies
    • 9.3.1 Overview

10. Company Profiles

  • 10.1 Shenzhen Mindray Bio-Medical Electronics Co Ltd
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Products and Services
    • 10.1.4 Financial Overview
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 Stryker Corp
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Products and Services
    • 10.2.4 Financial Overview
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 Schiller AG
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Products and Services
    • 10.3.4 Financial Overview
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 Mediana Co Ltd
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Products and Services
    • 10.4.4 Financial Overview
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 Nihon Kohden Corp
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Products and Services
    • 10.5.4 Financial Overview
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments
  • 10.6 Asahi Kasei Corp
    • 10.6.1 Key Facts
    • 10.6.2 Business Description
    • 10.6.3 Products and Services
    • 10.6.4 Financial Overview
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Developments
  • 10.7 Koninklijke Philips NV
    • 10.7.1 Key Facts
    • 10.7.2 Business Description
    • 10.7.3 Products and Services
    • 10.7.4 Financial Overview
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Developments

11. Appendix

  • 11.1 About Us
  • 11.2 Glossary of Terms